Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox Film-coated Tablet vs Dispersible Tablet in Iron Overload
NCT02125877Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of deferasirox in hemochromatosis (HH), sponsored by Novartis. Started Jul 2014; status: completed.
02
Drugs
deferasirox
03
Conditions
hemochromatosis (HH)
Beyond the preview
Go deeper on NCT02125877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125877.